Method for treating a GD2 positive cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9777068
SERIAL NO

14409161

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient as a continuous intravenous infusion over 24 hours per day.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APEIRON BIOLOGICS GMBHVIENNA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Groiss, Franz Langenzersdorf, AT 3 14
Janzek-Hawlat, Evelyne Vienna, AT 8 56
Ladenstein, Ruth Vienna, AT 11 49
Lode, Holger Greifswald, DE 4 14
Loibner, Hans Vienna, AT 61 199
Mutschlechner, Oliver Wiener Neudorf, AT 10 49
Peball, Bernhard Vienna, AT 8 51
Schuster, Manfred Vienna, AT 47 939
Stranner, Stefan Vienna, AT 7 46
Wiederkum, Susanne Stubenberg am See, AT 3 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00